Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Selective estrogen receptor modulators: an update on recent clinical findings.

Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB.

Obstet Gynecol Surv. 2008 Mar;63(3):163-81. doi: 10.1097/OGX.0b013e31816400d7. Review.

PMID:
18279543
2.

Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.

Johnston SR.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4376s-4387s; discussion 4411s-4412s. Review.

PMID:
11916228
3.

The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.

Howell SJ, Johnston SR, Howell A.

Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):47-66. Review.

PMID:
14687597
4.

Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.

Lewis JS, Jordan VC.

Mutat Res. 2005 Dec 11;591(1-2):247-63. Epub 2005 Aug 3. Review.

PMID:
16083919
5.

A pharmacological review of selective oestrogen receptor modulators.

Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L Jr.

Hum Reprod Update. 2000 May-Jun;6(3):212-24. Review.

PMID:
10874566
6.
7.

Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.

Pinkerton JV, Goldstein SR.

Menopause. 2010 May-Jun;17(3):642-53. doi: 10.1097/gme.0b013e3181c4f1d6. Review.

PMID:
20107426
8.

Molecular mechanisms of selective estrogen receptor modulator (SERM) action.

Dutertre M, Smith CL.

J Pharmacol Exp Ther. 2000 Nov;295(2):431-7. Review.

9.

The future of the new selective estrogen receptor modulators.

Palacios S.

Menopause Int. 2007 Mar;13(1):27-34. Review.

PMID:
17448265
10.
11.

Estrogen receptors as therapeutic targets in breast cancer.

Ariazi EA, Ariazi JL, Cordera F, Jordan VC.

Curr Top Med Chem. 2006;6(3):181-202. Review.

PMID:
16515478
12.

Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.

Jordan VC, O'Malley BW.

J Clin Oncol. 2007 Dec 20;25(36):5815-24. Epub 2007 Sep 24. Review.

PMID:
17893378
13.

Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.

Park WC, Jordan VC.

Trends Mol Med. 2002 Feb;8(2):82-8. Review.

PMID:
11815274
14.

Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.

Thiebaud D, Secrest RJ.

Reprod Fertil Dev. 2001;13(4):331-6. Review.

PMID:
11800172
15.

SERMs: current status and future trends.

Morello KC, Wurz GT, DeGregorio MW.

Crit Rev Oncol Hematol. 2002 Jul;43(1):63-76. Review.

PMID:
12098608
16.

[Selective estrogen receptor modulators (SERMs) in the practice].

Nagykálnai T.

Magy Onkol. 2002;46(2):165-75. Epub 2002 Aug 29. Review. Hungarian.

17.

Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.

Robertson JF.

Cancer Treat Rev. 2004 Dec;30(8):695-706. Review.

PMID:
15541579
18.

[Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].

Maeda T, Ke HZ, Simmons H, Thompson D.

Clin Calcium. 2004 Oct;14(10):85-93. Review. Japanese.

PMID:
15577137
19.

Therapeutic targeting in the estrogen receptor hormonal pathway.

Katzenellenbogen BS, Frasor J.

Semin Oncol. 2004 Feb;31(1 Suppl 3):28-38. Review.

PMID:
15052541
20.

Selective estrogen receptor modulators (SERMS).

Diez-Perez A.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):720-34.

Supplemental Content

Support Center